| abstract |
Disclosed is a pharmaceutical composition effective for treating colorectal cancer, renal cancer, liver cancer, lung cancer, lymphocytic leukemia (particularly chronic lymphocytic leukemia), ovarian cancer, or pancreatic cancer. OGTA076, which is a protein detected and identified in membrane protein extracts of tissue samples of colorectal cancer, renal cancer, liver cancer, lung cancer, lymphocytic leukemia (especially chronic lymphocytic leukemia), ovarian cancer and pancreatic cancer An immunogenic composition comprising the fragment, OGTA076 or a nucleic acid encoding the fragment, or OGTA076 or the epitope-containing fragment and an immunostimulant. [Selection figure] None |